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ABSTRACT
One of the main challenges in limbal stem cell (LSC) biology and transplantation is the lack of
definitive cell surface markers which can be used to identify and enrich viable LSCs. In this study,
expression of 361 cell surface proteins was assessed in ex vivo expanded limbal epithelial cells.
One marker, CD200 was selected for further characterization based on expression in a small sub-
set of limbal epithelial cells (2.25  0.69%) and reduced expression through consecutive passag-
ing and calcium induced differentiation. CD200 was localized to a small population of cells at the
basal layer of the human and mouse limbal epithelium. CD200+cells were slow cycling and con-
tained the majority of side population (SP) and all the holoclone forming progenitors. CD200+
cells displayed higher expression of LSCs markers including PAX6, WNT7A, CDH3, CK14, CK15,
and ABCB5 and lower expression of Ki67 when compared to CD200−. Downregulation of CD200
abrogated the ability of limbal epithelial cells to form holoclones, suggesting an important func-
tion for CD200 in the maintenance and/or self-renewal of LSCs. A second marker, CD109 which
was expressed in 56.29  13.96% of limbal epithelial cells, was also found to co-localize with
ΔNp63 in both human and mouse cornea, albeit more abundantly than CD200. CD109 expression
decreased slowly through calcium induced cell differentiation and CD109+ cells were character-
ized by higher expression of Ki67, when compared to CD109− subpopulation. Together our data
suggest that CD200 expression marks a quiescent population of LSCs with holoclone forming
potential, while CD109 expression is associated with a proliferative progenitor phenotype. STEM
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SIGNIFICANCE STATEMENT
The cornea is the clear refractive window at the front of the eye that permits light to enter and
be focused on the back of the eye. Stem cells in the cornea endlessly produce new cells to
allow the window to remain clear and our eyes to function properly. A handful of proteins have
been identified to mark the stem cells in the cornea, but this process results in loss of cellular
viability. This study identified a novel cell surface marker, CD200, which enables enrichment of
quiescent corneal stem cells with holoclone forming potential.
INTRODUCTION
The cornea is the transparent front part of the
eye which together with the crystalline lens
focuses the light onto retina for visual proces-
sing [1]. Corneal epithelial integrity and function
is maintained by limbal stem cells (LSCs) which
are found in a narrow peripheral region of the
cornea, known as the limbus. Loss of LSCs
results in a clinical condition called limbal stem
cell deficiency (LSCD) characterized by chronic
ocular surface inflammation, neovascularization,
frequent stromal scarring, with consequent
corneal opacity, pain, and loss of vision [2].
Transplantation of autologous ex vivo
expanded LSCs from the healthy contralateral
eye onto the patient’s damaged eye is an
established and European Medicines Agency
authorized treatment for patients with total/
severe unilateral LSCD due to ocular surface
burns [3]. Our group has developed good
manufacturing practice (GMP) protocols for
the ex vivo expansion of LSCs and has success-
fully transplanted 32 patients with unilateral
aInstitute of Genetic Medicine,
Newcastle University,
Newcastle, United Kingdom;
bUCL Institute of Immunology
and Transplantation, London,
United Kingdom; cDepartment
of Genetics and
Developmental Biology, The
Ruth and Bruce Rappaport
Faculty of Medicine, Technion
- Israel Institute of
Technology, Haifa, Israel;
dTissue Services, NHS Blood
and Transplant, Liverpool,
United Kingdom; eFaculty of
Medical Sciences, Department
of Genetics, University of
Kragujevac, Serbia; fSPEBO
Medical, Leskovac, Kragujevac,
Serbia; gDepartment of
Ophthalmology, Royal Victoria
Infirmary, Newcastle
University, Newcastle, United
Kingdom
Correspondence: Majlinda Lako,
Ph.D., Stem Cell Sciences,
Newcastle University, Institute of
Genetic Medicine and Institute
for Ageing, International Centre
for Life, Central Parkway,
Newcastle upon Tyne NE1 3 BZ,
United Kingdom. Telephone:
00 44191 2418688; e-mail:
majlinda.lako@ncl.ac.uk
Received April 25, 2018;
accepted for publication August
09, 2018; first published online in
STEM CELLS EXPRESS August
29, 2018.
http://dx.doi.org/
10.1002/stem.2903
This is an open access article
under the terms of the Creative
Commons Attribution License,
which permits use, distribution
and reproduction in any medium,
provided the original work is
properly cited.
STEM CELLS 2018;9999:1–13 www.StemCells.com
TISSUE-SPECIFIC STEM CELLS
severe and total LSCD in phase I–II clinical trials [4]. Our
method is based on the ex vivo expansion of a 1 × 2 mm2 lim-
bal biopsy cultured on human amniotic membrane resulting in
the expansion of LSCs which migrate away from the explant
and acquire the expression of differentiated epithelial markers
resembling LSC migration and differentiation from the limbus
toward the center of the cornea [5]. Using the same GMP pro-
tocols, we have also expanded ex vivo autologous oral mucosa
epithelial cells which were used to successfully transplant two
patients with bilateral LSCD [6]. Currently, ex vivo expansion
strategies of limbal and other autologous epithelial stem cell
are labor intensive and often lack standardization, largely
because it is currently impossible to prospectively isolate pure
populations of these cells for research or clinical use. Until this
occurs, different centers will likely use specific techniques for
isolation and ex vivo culture of LSCs in their respective institu-
tions that have been developed and investigated in their indi-
vidual basic laboratories, rendering it impossible to compare
clinical success rates between clinical trials performed in differ-
ent centers around the world.
An obvious problem with current clinical treatments is that
transplanted cells are a heterogeneous cell population contain-
ing many cell types (ranging from epithelial, stromal stem and
progenitor cells, conjunctival and corneal epithelial cells, and
blood or vascular cells) in addition to LSCs, significantly affect-
ing safety and efficiency of treatment. This was best
highlighted by a landmark study published by Rama et al. who
showed that successful corneal regeneration was strongly cor-
related with the presence of more than 3% holoclone-forming
(ΔNp63α-bright) cells in ex vivo expanded cultures used for
grafting of patients with LSCD [7]. Various studies have
described morphological characteristics of LSCs (i.e., small cell
size, pigmentation, and high nuclear to cytoplasmic ratio) [8],
their slow cycling nature and location within clusters at pali-
sades of Vogt [9]; however these factors have not been linked
with LSC function and outcome of transplantation; hence har-
vesting a specific and purified sub-population of these cells
remains a major challenge. Several key putative markers have
already been identified including ΔNp63α, ABCG2, ABCB5,
C/EBPσ, Bmi1, and Notch-1 among others [10–13]; however it
is unclear whether these proteins are expressed by different
LSC sub-populations or different LSC subsets within each popu-
lation marked by a single putative marker.
Stem cell heterogeneity has been well described in various
stem cell compartments including blood, skin, and intestinal
epithelium pointing to the concomitant existence of multiple
types of stem cells with distinct everyday roles [14]. From
these studies, it has also emerged that these different stem
cell types are more adaptable than previously thought, in that
they have a “default” role under normal conditions, however
following perturbation, such as stimulation by injury, they can
fulfil distinct functions when required [14]. Some tissues may
contain rapidly cycling, committed progenitors which are
responsible for the majority of tissue maintenance, as well as
a population of slow-cycling stem cells which maintain a higher
degree of stemness and can act as alternative source of stem
cells in response to injury and stress [15]. To date, it is not yet
known whether corneal epithelium is also maintained by a
combination of such quiescent and cycling progenitors, how-
ever it is interesting to note that in the human cornea two dif-
ferent sub-populations have been identified: (a) Bmi1+,
C/EBPδ+, and ΔNp63α+ mitotically quiescent LSCs which gener-
ate holoclones in culture and (b) Bmi1−, C/EBPδ−, and
ΔNp63α+ population which respond to injury [16]. It is not
known whether LSC heterogeneity extends beyond the pres-
ence of these two LSC sub-populations and whether cell sur-
face markers to distinguish between these two subpopulations
can be identified.
In this study, we used the LEGEND Screen Lyophilized Anti-
body Panel Human Cell Screening Kit to identify cell surface
markers for human LSCs. Two markers, CD109 and CD200
were selected and studied in detail with respect to LSC prolif-
eration, differentiation, and colony forming efficiency. Our
data indicate that CD200 and CD109 expression mark quies-
cent LSC with holoclone forming potential and proliferative
limbal epithelial progenitors respectively.
MATERIAL AND METHODS
Corneal Tissue
Cadaveric adult human limbal tissue was obtained from the
corneo-scleral rings remaining (nine females, 15 males, aver-
age age 69.42 years, SEM 2.99, range 28–83 years) after
removal of the central cornea for transplantation supplied by
the NHS Blood and Transplant (NHSBT) Cornea Transplantation
Service eye bank in Manchester and Bristol, UK. Average time
from death to retrieval of corneo-scleral tissue was
16.1  1.99 hours (mean  SEM). Average time tissue spent
in organ culture was 36.55  7.8 days (mean  SEM). Human
tissue was handled according to the tenets of the Declaration
of Helsinki and informed consent was obtained for research
use of all human tissue from the next of kin of all deceased
donors. The study was approved by the NRES Committee
North East - Newcastle & North Tyneside 1 (REC number:
11/NE/0236, protocol number 5466) on the 29th October
2013.
Animal care and use conformed to the ARVO Statement
for the Use of Animals in Ophthalmic and Vision Research.
Immunostaining was performed on paraffin sections (5–7 μm)
of C57BL/6 mouse tissues, as described previously [17].
Single Cell Culture of Human Limbal Epithelium on
3T3-J2 Feeder Layers
Twenty four hours before limbal epithelial cell isolation from
corneo-scleral tissue, mitotically inactivated J2–3T3 mouse
fibroblasts were suspended in high-glucose DMEM supplemen-
ted with bovine calf serum (10%) (Hyclone, Pittsburgh, USA)
and penicillin/streptomycin (1%) (Thermo Fisher Scientific,
Waltham, MA, USA) and plated in a 9.6 cm2 tissue culture well
at the final density of 2.4 × 104 cells per cm2 as previously
described [18]. The use of bovine calf serum instead of fetal
calf serum was recommended by the manufacturer of the
3T3-J2 cell line (Karafast, New York, USA). The 3T3 cell suspen-
sion was placed in a tissue culture incubator at 37C overnight
to allow the establishment of a 3T3 feeder layer. On the fol-
lowing day, LSCs were harvested from cadaveric corneo-scleral
rims as previously described [19]. The deeper layers of the
corneo-scleral rings were dissected away together with excess
sclera leaving a ring containing approximately 2 mm of periph-
eral cornea and 2 mm of adjacent sclera. The remaining tissue
containing limbal epithelium was then cut into smaller 1 mm2
© 2018 The Authors Stem Cells published by
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pieces. The limbal epithelial cells were isolated from these
pieces using serial trypsinization with 0.05% trypsin–EDTA
solution (Thermo Fisher Scientific, USA). After 20 minutes incu-
bation in a tissue culture incubator, the resulting cell suspen-
sion was removed from the limbal pieces and epithelial
medium was added to this suspension. After the cell suspen-
sion was centrifuged for 3 minutes at 1,000 rpm in Heraeus
Megafuge 16R Centrifuge (Thermo Fisher Scientific, USA), the
supernatant was removed and the remaining cell pellet was
re-suspended in epithelial medium containing 3:1 mixture of
low-glucose DMEM:F12 supplemented with fetal calf serum
10%, penicillin/streptomycin 1% (all Thermo Fisher Scientific,
USA), hydrocortisone 0.4 μg/ml, insulin 5 μg/ml, triiodothyro-
nine 1.4 ng/ml, adenine 24 μg/ml, cholera toxin 8.4 ng/ml, and
EGF 10 ng/ml (all Sigma-Aldrich, Gilingham, UK). The trypsini-
zation and centrifugation process was repeated a further three
times using the same limbal tissue and the same centrifuge
and settings. The resulting cell suspensions were pooled
together. After counting, 30,000 of viable limbal epithelial cells
(trypan blue exclusion test) in epithelial medium were added
to one 9.6 cm2 tissue culture well containing the growth
arrested 3T3 fibroblast and placed in a tissue culture incubator
at 37C with a humidified atmosphere containing 5% CO2. The
medium was exchanged on the third culture day and every
other day thereafter. After 3T3 feeder cells were detached and
removed using 0.02% EDTA (Manchester, UK), sub-confluent
primary cultures were dissociated with 0.5% trypsin–EDTA
(Santa Cruz, California, USA) to single cell suspension and pas-
saged at a density of 6 × 103 cells/cm2. For serial propagation,
cells were passaged and cultured as above, always at the stage
of sub-confluence, until they reached passage 3.
Limbal Epithelial Cell Surface Marker Screening
Limbal epithelial cell cultures (passage 1) were dissociated as
described above to a single cell suspension. Limbal epithelial
cells were stained with 361 different phycoerythrin
(PE) labeled antibodies and 10 immunoglobulin isotype con-
trols using the LEGEND Screen Lyophilized Antibody Panel
Human Cell Screening (PE) Kit (700007, BioLegend, San Diego,
USA). After the staining, cells were washed and analyzed by
LSR Fortessa (BD, USA) flow cytometer. Data were analyzed
with FCS Express 6 Flow Cytometry Software (De Novo Soft-
ware, Los Angeles, USA). The screening was repeated three
times, for each experiment corneo-scleral rings from seven
donors were pooled (21 donors in total; eight females,
13 males, average age 70.50 years, SEM 2.06, range
55–83 years).
Calcium Induced Differentiation
Limbal epithelial cells from three different donors (n = 3, pas-
sage 1) were plated at a density of 200,000 cells per well in a
six well plate and cultured in EpiGRO Human Ocular Epithelia
Complete Media Kit (SCMC001, Merck Millipore, New York,
USA) without 3T3-J2 feeders or any plate coating. The medium
contained basal medium, supplements mix (L-Glutamine 6 mM,
Epinephrine 1.0 μM, Insulin 5 μg/ml, Apo-Transferrin 5 μg/ml,
Hydrocortisone 100 ng/ml, EpiFactor O proprietary, and EpiFac-
tor P 0.4%), 150 μM calcium and 1% penicillin/streptomycin.
When the cells reached 80% confluence, calcium was added to
a final concentration of 1.2 mM, for the induction of
differentiation. Cells were differentiated for up to 1 week and
collected for flow cytometry analysis.
Flow Cytometry Analysis and Fluorescence-Activated
Cell Sorting
The expression of selected markers in limbal epithelial cell cul-
tures was monitored through subsequent passages, from pas-
sage one to passage four, and during calcium induced
differentiation using cells from three different donors (n = 3)
to provide biological triplicates. After trypsin dissociation, lim-
bal epithelial cells re-suspended in flow buffer (1% Bovine
Serum Albumin in PBS) were stained for 20 minutes with dif-
ferent selected antibodies on ice and analyzed by flow cytome-
try (FACSCanto II, BD, North Carolina, USA). A minimum of
10,000 events were recorded for each sample. Antibodies used
for fluorescence-activated cell sorting (FACS) were PE-
conjugated anti-human CD200 (329205, BioLegend, USA, dilu-
tion factor 1:100), PE-conjugated anti-human CD109 (323305,
BioLegend, USA, 1:100) and APC-conjugated anti-human p63
delta (NBP2-33090, Novus Biologicals, Abingdon, UK,
USA, 1:100).
FACS was carried out using a FACSAria II sorter (BD, USA).
Limbal epithelial cells used for the cell sorting experiments
were passage 1. The limbal epithelial cell staining was per-
formed as above using FACS buffer (1% FBS in PBS) under
aseptic conditions for both final candidate markers, CD200 and
CD109. The stained cell suspension was then filtered through a
40 μm nylon filter to remove any cell clumps. DAPI stain (10%)
was added to a final cell suspension to eliminate dead cells.
Side scatter and forward scatter profiles were used to elimi-
nate cell doublets. Positive and negative sorted cells were used
for colony-forming efficiency assay (CFE), clonal assay, and
quantitative reverse transcriptase polymerase chain reaction
(qRT-PCR).
CFE and Clonal Assay
CFE was performed as previously described by Yu et al. [18].
Following staining with 1% Rhodamine B, colonies were
counted under dissecting microscope (SMZ645, Nikon, Tokyo,
Japan). The CFE was calculated as number of colonies formed/
number of cells plated × 100 for both positive and negative
cell populations for three different donors (n = 3). Each donor
served as a biological replicate. Sorted limbal epithelial cells
from three different donors were also plated for clonal assay
(n = 3) performed as described by Dziasko et al. [20]. Limbal
epithelial cells used for the cell sorting experiments were pas-
sage 1. The sorted populations were re-plated for CFE and
clonal assay. The clonal type was determined by (a) the mor-
phology of colonies and (b) the percentage of aborted colonies
as follows: when <5% of the total colonies were terminally dif-
ferentiated, the clone was scored as a holoclone; when more
than 95% of colonies were terminally differentiated, the clone
was scored as a paraclone and finally, when >5% but <95% of
colonies were terminally differentiated, the clone was classi-
fied as a meroclone [21, 22].
Fluorescence Immunocytochemistry and Microscopy
Cultured limbal epithelial cells, human frozen corneal sections
and paraffin sections of mouse and human cornea were fixed
for 15 minutes either in 4% paraformaldehyde (CD200 stain-
ing) or in ice-cold methanol (CD109 staining). A blocking step
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was performed by incubation in antibody diluent containing
1% bovine serum albumin (Sigma-Aldrich, UK) with 5% normal
goat serum (Thermo Fisher Scientific, USA) for 30 minutes
prior to staining. Permeabilization with 0.2% Triton X-100 in
PBS was performed prior to staining with antibodies for inter-
nal cell markers. Cells were incubated with primary antibodies
at 4C overnight and further incubated with secondary anti-
bodies for 1 hour. The following primary antibodies were used
at the indicated dilutions: anti CD109 (sc-271085, Santa
Cruz, USA, 1:200), anti-human CD200 (329201, BioLegend,
USA, 1:200), anti-mouse CD200 (AF3355, Novus Biologicals, USA,
1:100), anti p63 delta (NBP2-29467, Novus Biologicals, USA,
1:200), anti-cytokeratin 15 (ab52816, Abcam, Cambridge, UK,
1:100), and anti Ki67 antibody (ab15580, Abcam, UK, 1:100). Sec-
tions were mounted in Vecta shield (Vector Labs, Peterborough,
USA) with Hoechst 33342 (1:1,000, Thermo Fisher Scientific,
USA). Images were obtained using Axio Imager microscope with
ApoTome accessory equipment and AxioVision software (Zeiss,
Jena, Germany).
Quantitative Reverse Transcriptase Polymerase Chain
Reaction
As in previous experiments, passage one of cultured limbal
epithelial cells obtained from three different donors were used
for the cell sorting (n = 3). The sorted cell populations were
then subjected to qPCR analysis. cDNA was synthesized using
the Cells-to-cDNA II kit (AM1723, Ambion, Thermo Fisher Sci-
entific, USA) directly from cell lysates as per the manufac-
turer’s protocol. Each reaction was set up using Go-Taq qPCR
Master Mix (Cambridge, UK) and was composed of 5 μl X2
Master Mix buffer, 0.4 μl forward primer, 0.4 μl reverse primer,
0.8 μl template cDNA, 3.7 μl RNAse-free water, and 0.1 μl COX.
All reactions were analyzed on a QuantStudio 7 Flex Real Time
PCR System (Thermo Fisher Scientific, USA) according to the
manufacturer’s instructions using SYBR Green as the detection
dye, and ROX channel to detect COX as the reference dye. A
standard, 40-cycle qPCR was performed for each sample. The
primer sequences used for qRT-PCR are listed in Supporting
Information Table S1. The data was analyzed using the 2-ΔΔCt
calculation method.
Cell Proliferation Assay
Passage one of limbal epithelial cells from three different
donors (n = 3) at 60%–70% confluence were exposed to BrdU
at a final concentration of 10 μM in cell culture medium and
incubated for 1, 4, and 8 hours. Control cells were cultured
without BrdU. After incubation, cells were stained with PE con-
jugated anti-CD200 antibody (329205, BioLegend, USA) for
20 minutes on ice, then were washed, fixed, and permeabilized
before DNAse treatment. Following BrdU epitope exposure
cells were stained with PerCP-Cy5.5 conjugated anti-BrdU anti-
body (560809, BD, USA, 5 μl per test) and DAPI stain for cell
cycle analysis and analyzed by LSR Fortessa (BD, USA) cell
analyser.
Hoechst 33342 and Pyronin Y Staining for G0/G1
Separation
Quiescent cells, which are arrested in G0 phase, have lower
level of RNA compared to active cells (G1 phase). Hoechst is
an exclusive DNA dye while Pyronin Y reacts with both DNA
and RNA. However, in the presence of Hoechst, Pyronin Y
reaction with DNA is blocked, and Pyronin Y stains RNA only.
When cells are stained first with Hoechst 33342 and then with
Pyronin Y it is possible to distinguish DNA from RNA. Limbal
epithelial cells from three different donors (n = 3) were stained
with APC conjugated anti-CD200 antibody for 20 minutes
(329207, BioLegend, USA). For the separation of G0 and G1
cell cycle phases, limbal epithelial cells were stained with
Hoechst 33342 (Sigma-Aldrich, UK) in a final concentration
10 μg/ml and incubated at 37C for 45 minutes. After
45 minutes, 5 μl of 100 μg/ml Pyronin Y (Sigma-Aldrich, UK)
was added directly to the cells and incubated at 37C for a fur-
ther 15 minutes. Single color controls and negative control
were also prepared. LSR Fortessa (BD, USA) flow cytometer
was used to analyze cells.
Small Interfering RNA Transfection
To investigate the impact of CD200 downregulation on the
clonal ability of limbal epithelial cells, RNA interference (RNAi)
was performed using small interfering RNA (siRNA). Passage
one human limbal epithelial cells from three different donors
were grown on 3T3 feeder layer in complete epithelial
medium supplemented with EGF, adenine, cholera toxin,
hydrocortisone, insulin, and triiodothyronine. A day before
transfection, limbal epithelial cells (150 × 103) were re-seeded
in 12-well plate without feeders in order to increase transfec-
tion efficiency. The day after re-seeding cells were transfected
with CD200 Human Stealth siRNAs (set of three: HSS106678,
HSS106679, HSS181160; 1299003, Thermo Fisher) and Stealth
RNAi siRNA Negative Control Lo GC (12935200, Thermo Fisher)
using Lipofectamine RNAiMAX Transfection Reagent
(13778030, Thermo Fisher) according to the manufacturer’s
protocol. The transfected cells were incubated for 48 hours for
CFE and clonal assay.
After 48 hours incubation with CD200 siRNA and control
siRNA, cells we re-seeded back to six well plates in different
densities (500 and 1,000 cells/well) and cultured on 3T3
feeders for next 14 days. The rest of the cells were used for
RNA extraction and qRT-PCR to confirm CD200
downregulation.
Statistical Analysis
GraphPadPrism 7.0 (San Diego, CA, https://www.graphpad.
com/scien-tific-software/prism/) was used to perform all statis-
tical analyses. The data showed normal distribution therefore
Student’s t test was used to analyze differences between
groups and p ≤ .05 was considered statistically significant. All
experiments were performed in biological replicates of three
or more, and data are presented as mean  SEM.
RESULTS
Flow Cytometric Based Cell Surface Screening of Limbal
Epithelial Cell Cultures
After removing 3T3 feeder cells with EDTA, passage one sub-
confluent limbal epithelial cells were lifted from the tissue cul-
ture plates using Trypsin–EDTA and stained with 361 human
surface proteins and analyzed by flow cytometry. The cell sur-
face marker screening was performed three times and in each
case, limbal epithelial cells from seven different donors were
pooled to obtain sufficient cell number for this type of
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analysis. A summary of these results is shown in Supporting
Information Table S2. LEGEND Screen analysis confirmed high
expression of the commonly cited limbal epithelial cell markers:
EGFR (88.81  6.02) [8, 23, 24], SSEA-4 (54.02  5.93%) [25],
CD71 (88.76  5.92) [8, 26], integrin β5 (91.45  1.24) [27],
integrin α6 (92.54  6.41) [26], E-cadherin (88.48  6.06)
[11] as well as many other general markers of corneal epi-
thelium. The presence of other markers previously related
to limbal epithelial cells was also confirmed: CD40
(26.00  6.94) [28], CD117 (c-kit) (8.22  2.56) [29, 30],
CD146 (67.04  2.87), and CD166 (95.08  0.97) [30] as
well as the presence of putative LSC marker integrin α9/β1
(4.85  1.98) [8, 11, 24, 30, 31]. The expression of the autop-
hagy marker LAMP1 (84.82  11.89) was also high, corrobo-
rating with previously reported data on limbal epithelial
cultures [32].
Marker selection for further investigation was based on
three criteria: (a) presence in a small subpopulation of cells
(up to 10%) in accordance with label retaining cells in the lim-
bal zone making up less than 10% of the total population
(assessed on the basis of the percentage of radiolabeled thy-
midine retaining cells present in the limbal zone [33]) and the
studies of Umemoto and co-workers showing that approxi-
mately 10% of total limbal epithelial cells expressed the puta-
tive LSC marker ABCG2 [34]; (b) passage or calcium
differentiation induced reduction in expression frequency in
limbal epithelial cells; and (c) presence in other epithelial stem
or progenitor cells. CD200 (2.25  0.69%, n = 3) was one of
the few markers that fulfilled all these three criteria [35–38]
and was selected for further characterization. In addition to
LSC markers, we also selected putative transient amplifying cell
surface markers based on similar expression to ΔNp63
(assessed by our group to be expressed in 45%–60% of ex vivo
expanded limbal epithelial cells [18]) as well as passage and
differentiation induced reduction in expression frequency in
limbal epithelial cells. CD109 (56.29  13.96%, n = 3) was
among the cell surface marker that fulfilled these criteria and
was selected for further characterization.
The Expression of CD109 in Human Limbal Epithelial
Cell Cultures, Human, and Murine Corneas
The LEGEND Screen results were confirmed by flow cytometric
analysis which showed CD109 to be expressed in a relatively
high percentage of limbal epithelial cultures in p1
(47.51  9.35%, n = 5) (Fig. 1A). The expression of CD109 did
not vary significantly through the first four passages (p > .05)
(Fig. 1A). Nonetheless, the expression of CD109 decreased sig-
nificantly (p < .05) after 5 days of calcium-induced differentia-
tion under feeder-free conditions similarly to ΔNp63
expression (p < .05) (Fig. 1B).
Using immunostaining, we determined the localization of
CD109+ cells in human ocular surface epithelial tissues
(Fig. 1C). CD109+ cells were exclusively located at the limbus
and co-localized with ΔNp63 (Fig. 1C), while undetectable in
the suprabasal and superficial layers of limbal epithelium as
well as in the all layers of central corneal epithelium (Fig. 1C).
In murine corneal tissue, CD109 (Fig. 1D) was also exclusively
located at the limbus and co-localized with ΔNp63 and CK15
while absent in central corneal epithelium. In vitro,
CD109+cells were present predominantly on the outer border
of colonies (Fig. 1E).
Colony Forming Efficiency and Proliferative Ability of
CD109+ Cells
To identify actively replicating cells, and thereby assess cellular
proliferation, BrdU was applied to cells in culture and the num-
ber of cells in the S phase was monitored after 1, 4, and 8 hours
incubation with BrdU by flow cytometry. No statistically signifi-
cant differences were found in the percentage of cells in the S
phase of the cell cycle for CD109+ or CD109− population after
incubation with BrdU for 1 and 4 hours. However, after 8 hours
incubation with BrdU, there was a significantly higher number
of CD109+ cells in the S phase compared do CD109− cells
(Fig. 1F: p = .0073, Supporting Information Fig. S1D).
Sorted positive and negative cells for both markers were
tested for their colony forming efficiency and clonal potency
(n = 3). There were no significant differences between the posi-
tive and negative cells in CFE (Fig. 1H); however the relative
colony-covered-area size was significantly greater in CD109+cells
(p < .01), meaning they formed larger colonies (Fig. 1G, 1I)
when compared to CD109− cells. Despite the fact that both
CD109+ and CD109− cells formed colonies classified as mero-
clones, number of aborted colonies was significantly higher
(p = .0047) in CD109− population (Fig. 1J, 1K).
The Expression of CD200 in Human Limbal Epithelial
Cell Cultures, Human, and Murine Corneas
CD200 was expressed in a small percentage of limbal epithelial
cultures in p1 (4.13  1.10%, n = 10) (Fig. 2A). Furthermore, the
expression of CD200 decreased significantly (p < .05) and rapidly
through subsequent passages (Fig. 2A). During calcium induced
differentiation, the expression of CD200 disappeared from the
culture after 5 days (p < .05) (Fig. 2B). For all the markers,
including CD109, CD200, and ΔNp63, a lower expression was
observed under feeder-free culture conditions used for the
calcium-induced differentiation assays, which may suggest that
the feeder-free culture is less conducive to LSC maintenance.
The presence of CD200+ cells was confirmed in the basal
layer of the limbal epithelium, while its expression was absent
in all the other layers of limbal and corneal epithelium
(Fig. 2C). In murine corneal tissue, CD200 (Fig. 2D) was exclu-
sively located at the limbus and co-localized with ΔNp63 and
CK15 while absent in other parts of corneal epithelium.
CD200+ cells were also present in ex vivo expanded limbal epi-
thelial cell cultures, but in lower number compared to CD109+
cells and moreover were found scattered throughout the colo-
nies (Fig. 2E). CD200+ cells (3.66  0.25%) were much less
abundant than ΔNp63+ cells (47.65  3.01%) (Fig. 2E, Support-
ing Information Fig. S1A). All CD200+ cells were also ΔNp63+;
however ΔNp63+ CD200+ cells represented only 6.23  0.97%
of all ΔNp63+ cells (Supporting Information Fig. S1B).
Colony Forming Efficiency and Proliferative Ability of
CD200+ Cells
The proliferative potential of CD200+ cells was examined by Ki67
immunofluorescent staining of limbal epithelial cells cultured
in vitro (Fig. 2F). Interestingly, while some CD200+cells were Ki67+
(41.67  0.22%), there were more Ki67− cells in the CD200+ pop-
ulation (58.33  0.22%) (Supporting Information Fig. S1C).
There were no statistically significant differences in CFE
between CD200+ and CD200− groups (Fig. 3B), however
CD200+ cells were exclusively able to form holoclones—large
© 2018 The Authors Stem Cells published by
Wiley Periodicals, Inc. on behalf of AlphaMed Press 2018
www.StemCells.com
Bojic et al. 5
Figure 1. CD109 expression in human and mouse cornea in vivo and during ex vivo expansion of human limbal epithelial cells. (A):
Quantification of CD109 expression through different passages of limbal epithelial cells by flow cytometry. Values represent mean  SEM,
n = 3–5 (n, number of biological replicates). (B): Quantification of ΔNp63 and CD109 expression during calcium induced differentiation of
limbal epithelial cells by flow cytometry. Values represent mean  SEM, n = 3, *, p < .05. (C): Immunohistochemical staining of human
corneal tissue cryosections for ΔNp63 and CD109 within the central cornea and limbus. Nuclei are shown by Hoechst counter staining.
Scale bars 50 μm with exception of additional inset with higher magnification with scale bar of 20 μm. (D): Immunohistochemical staining
of murine corneal tissue cryosections for CK15, ΔNp63, and CD109 within the central cornea and limbus. Nuclei are shown by DAPI coun-
ter staining. The dashed line indicates the stromal-epithelial junction. Red arrows point at the limbal region. Scale bars 20 μm. (E): CD109
© 2018 The Authors Stem Cells published by
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colonies with smooth, thick borders (Fig. 3D), while CD200−
cells formed meroclones which were characterized by irregular
borders (Fig. 3E). The number of aborted colonies was signifi-
cantly higher in CD200− population (p = .0061). Using the per-
centage of terminal colonies described in the methods,
CD200+ colonies were scored as holoclones (Fig. 3A) while
CD200− colonies were scored as meroclones (Fig. 3C).
CD200+ cells were slow to enter S phase: at 1 and 4 hours
there were significantly less CD200+ in S phase when compared
to CD200−; these differences became non-significant at 8 hours
(Fig. 3F, 3G). For that reason we used Hoechst 33342 and Pyronin
Y staining for G0/G1 separation. A larger part of G0 subpopula-
tion was made up by CD200+ cells (59.30  3.12%) than CD200−
cells (40.70  2.11%; Fig. 3H). Interestingly, we also found that
majority (78.66  3.20%) of SP cells were in the CD200+ popula-
tion (Supporting Information Fig. S1E) while the CD200− popula-
tion contained less SP cells (21.34  3.20%; Fig. 3I).
The Expression of LSC Markers in the CD109 and CD200
Positive and Negative Populations
To investigate the transcriptional profile of CD109+ and
CD200+ cells, expression of putative LSC markers ΔNp63,
ABCB5, C/EBPδ, BMI1, AXIN2, FZD7, CHD3, WNT7A, CK14, and
CK15 [12, 16, 39–43], corneal epithelial differentiation marker
CK3 [44] and marker of proliferative cells Ki67 [45] was
assessed by qRT-PCR.
The expression of CD109, was significantly higher (p < .01)
in CD109+ group compared to CD109− group, thus validating
the flow activated cell sorting strategy. In addition, the expres-
sion of LSC markers PAX6 (p < .05) and CK14 (p < .01) and pro-
liferative marker Ki67 (p < .001) was also higher in the CD109+
group when compared to the CD109− (Fig. 4A). No statistically
significant differences were found in the expression of other
LSC markers ΔNp63, ABCB5, C/EBPδ, BMI1, AXIN2, FZD7,
CHD3, WNT7A, and CK15 and corneal differentiation marker
CK3 between the CD109+ and CD109− group (Fig. 4A).
CD200 was significantly upregulated in CD200+ cell population
(p < .001) along with the putative LSC markers ABCB5 (p < .001),
CDH3 (p < .001), PAX6 (p < .01),WNT7A (p < .01), CK14 (p < .01),
and CK15 (p < .001). On the other hand, ΔNp63 and Ki67
(p < .05) were significantly downregulated in CD200+ cell popula-
tion compared to the CD200− cell population. There were no sig-
nificant differences in the expressions of C/EBPδ, BMI1, AXIN2,
FZD7, and CK3 between the CD200+ and CD200− groups (Fig. 4B).
CD200 siRNA Transfection
To investigate the impacts of CD200 downregulation on limbal
epithelial cell cultures, RNAi was carried out using a pool of
three different siRNAs as detailed in the materials and
methods section. Quantitative RT-PCR analysis confirmed
downregulation of CD200 in the group treated with CD200
siRNA compared to control group (p < .05) (Fig. 5A).
Interestingly, the colony forming efficiency assay showed no
significant difference in the percentage of formed paraclones
or meroclones between the two groups (Fig. 5B, 5C), but holo-
clones completely disappeared from the siRNA transfected
group (Fig. 5C, 5D), leading to a significant difference of the
percentage of holoclones formed between the
groups (p < .05).
DISCUSSION
LSCs are tissue-specific stem cells with a high proliferative
potential and self-renewal capacity responsible for the life-long
maintenance of corneal tissue in both homeostasis and wound
repair [11, 46, 47]. To date, a few putative LSC markers
(e.g., ΔNp63, ABCG2, C/EBPδ, BMI1, PAX6, WNT7A, ABCB5)
have been associated with LSCs, however, among these, only
ABCB5 represents a cell surface marker that enables enrich-
ment of viable LSCs. In this study, we used the LEGEND Screen
Lyophilized Antibody Panel to assess the expression of 361 cell
surface markers in ex vivo expanded limbal epithelial stem
cells and selected CD200 and CD109 as cell surface markers of
interest for further investigation.
Up to date, there are no reports of either CD109 or CD200
expression or functional significance in the corneal epithelium.
CD109 is a glycosylphosphatidylinositol–anchored glycoprotein
whose expression is upregulated in several types of human
cancers, particularly squamous cell carcinomas, while in nor-
mal human tissues CD109 expression is limited to certain cell
types including myoepithelial cells of mammary, lacrimal, sali-
vary, and bronchial glands, basal cells of the prostate and
bronchial epithelium [48], human hepatic progenitor cells [49],
endothelial cells and a subpopulation of bone marrow CD34+
cells enriched in hematopoietic stem and progenitor cells [50].
CD109 has been shown to enhance EGF-signaling in the SK-
MG-1 glioblastoma cell line through the interaction of mem-
brane anchored N-terminal CD109 fragment with EGFR [51],
and to negatively regulate TGF-β1 signaling in keratinocytes by
either directly modulating receptor activity or by binding of
soluble CD109 to type I TGF-β receptor [52, 53]. TGF-β is an
important cytokine that negatively regulates proliferation of
different cell types including primary cultured human limbal
epithelial cells [54]. Mii et al. reported that CD109-deficient
mice exhibit epidermal hyperplasia and chronic skin inflamma-
tion, and CD109 regulates differentiation of keratinocytes
in vivo [48]. Taken together these data show that the CD109
molecule plays an important role in epithelial cell proliferation
through the positive regulation of EGF and negative regulation
of TGF-β signaling as well as being involved in epithelial cell
differentiation.
Our results showed that CD109 is expressed in both
human and mouse corneal epithelium and is co-localized with
ΔNp63 in the basal layer of the limbal epithelium while is
immunohistochemical staining of human limbal epithelial colony in vitro. Nuclei are shown by Hoechst counter staining. Scale bar 50 μm.
(F): Quantification of cells in the S phase of the cell cycle in CD109+ and CD109− population after 1, 4, and 8 hours incubation with BrdU.
Values represent mean  SEM, n = 3, **, p < .001. (G): Colonies of CD109+ limbal epithelial cells stained with 2% rhodamine. (H): Com-
parison of colony forming efficiency between CD109+ and CD109− cell populations. Values represent mean  SEM, n = 3–5. (I): Colonies
of CD109− limbal epithelial cells stained with 2% rhodamine. (J): Pie chart showing the distribution of formed and aborted colonies in
CD109+ population. (K): Pie chart showing the distribution of formed and aborted colonies in CD109− population. Abbreviations: ep, epi-
thelium; st, stroma.
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Figure 2. CD200 expression in human and mouse cornea in vivo and during ex vivo expansion of human limbal epithelial cells. (A):
Quantification of CD200 expression through different passages of limbal epithelial cells by flow cytometry. Values represent mean  SEM,
n = 3–10 (n, number of biological replicates), *, p < .05. (B): Quantification of CD200 expression during calcium induced differentiation of
limbal epithelial cells by flow cytometry. Values represent mean  SEM, n = 3, *, p < .05. (C): Immunohistochemical staining of human
corneal tissue paraffin sections for ΔNp63 and CD200 within the central cornea and limbus. Nuclei are shown by Hoechst counter stain-
ing. Scale bars 20 μm. (D): Immunohistochemical staining of murine corneal tissue cryosections for CK15, ΔNp63, and CD200 within the
central cornea and limbus. Nuclei are shown by DAPI counter staining. The dashed line indicates the stromal-epithelial junction. Red
arrows point at limbal region. Scale bars 20 μm. (E): Immunohistochemical staining of limbal epithelial cell colonies in vitro for CD200 and
ΔNp63. Blue arrow points CD200+ cells. Nuclei are shown by Hoechst counter staining. Scale bar 50 μm. (F): Immunohistochemical stain-
ing of limbal epithelial cell colonies in vitro for CD200 and Ki67. Red arrows point to CD200+ Ki67+ cells; orange arrows point to
CD200+Ki67− cells. Nuclei are shown by Hoechst counter staining. Scale bar 50 μm. Abbreviations: ep, epithelium; st, stroma.
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Figure 3. Colony forming efficiency and proliferative potential of sorted CD200 positive and negative population. (A): Pie chart showing
the distribution of formed and aborted colonies in CD200+ population. (B): Comparison of colony forming efficiencies of CD200+ and
CD200− cells. Values represent mean  SEM, n = 3 (n, number of biological replicates). (C): Pie chart showing the distribution of formed
and aborted colonies in CD200− population. Values represent mean  SEM, n = 3. (D): Microscopic and macroscopic appearances of colo-
nies formed by CD200+ cells. Scale bars 100 μm. (E): Microscopic and macroscopic appearances of colonies formed by CD200− cells. Scale
bars 100 μm. (F): BrdU cell proliferation assay of CD200 negative and positive limbal epithelial cell population after 1- and 8-hours incuba-
tion with BrdU. Values represent mean  SEM, n = 3.(G): Quantification of cells in the S phase of the cell cycle in CD200+ and CD200−
population after 1, 4, and 8 hours incubation with BrdU. Values represent mean  SEM, n = 3, *, p < .05. (H): The contribution of CD200+
and CD200− cell population to the total number of cells in the G0 phase of the cell cycle. Values represent mean  SEM, n = 3. (I): The
contribution of CD200+ and CD200− cell population to the total number of side population cells. Values represent mean  SEM, n = 3.
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absent in the other layers of the limbal epithelium and all
layers of the central corneal epithelium. In vitro, CD109+ cells
were located at the edge of growing colonies, similar to
ΔNp63 expression in proliferating cells at the periphery of
holoclones as previously reported [55]. Moreover, CD109
expression decreased during calcium-induced differentiation in
a similar manner to ΔNp63 expression. There were more
CD109+ cells in S phase of the cells cycle after 8 hours incuba-
tion with BrdU. This observation together with the higher Ki67
expression and larger colony area formed by the CD109+ cells
suggest that CD109 represents a cell surface marker for prolif-
erating corneal epithelial progenitor cells.
Previous studies have suggested the presence of a stem
cell niche at the bulge region of the hair follicle, which con-
tains CD200+ cells [35, 37, 38, 56, 57] and have shown enrich-
ment of human bulge stem cells by positive selection using
CD200 as a cell surface marker [58]. CD200 (also known as OX-
2) is a transmembrane glycoprotein that transmits an immuno-
regulatory signal through its receptor (CD200R) to attenuate
inflammatory reactions and promote immune tolerance [37].
CD200/CD200R mediated intracellular communication among
different epidermal cell sub-populations may have an impor-
tant role in preventing undesired immune responses in the
skin [59]. Hair follicles represent one of the few sites of
“immune privilege” [60], possibly with the aim of preserving
keratinocyte stem cells [61]. The CD200 molecule therefore
may play a vital role in this “protection” since CD200/CD200R
interaction attenuates perifollicular inflammation and prevents
hair follicle specific autoimmunity, thereby protecting the epi-
dermal stem cell reservoir from autoimmune destruction [62].
Additionally, CD200 has a clinical importance in allo- and xeno-
transplantation [63]. CD200 overexpression in transgenic mice
increases skin, cardiac, and renal allograft survival [64] by sup-
pression of inflammation and acquired immunity. Apart from
normal tissues, high CD200 expression was found in colon can-
cer, myeloma, breast and brain cancer, melanoma and normal
mesenchymal stem cells [65]. It is closely related to tumor
immunosuppression and has been proposed as a cancer stem
cell marker in colon cancer [65]. CD200 has also been pro-
posed as a putative marker of corneal endothelial cells that
enables their differentiation from stromal keratocytes and cor-
neal stromal fibroblasts [66]. We also observed CD200+ corneal
endothelial cells in human corneal sections corroborating data
published by Cheong et al. [66] (data not shown).
Figure 5. CD200 knockdown and its effect on clonal ability of
limbal epithelial cells. (A): Quantitative reverse transcriptase poly-
merase chain reaction expression data for control siRNA versus
CD200 siRNA treated limbal epithelial cells. Values represent
mean  SEM, n = 3 (n, number of biological replicates), *, p < .05.
(B): Pie chart showing distribution of paraclones, meroclones, and
holoclones formed by control siRNA treated cells and (C) CD200
siRNA treated cells. (D): Representative images of colonies formed
in control and CD200 siRNA group, with 500 or 1,000 cells seeded
per well. Abbreviation: siRNA, small interfering RNA.
Figure 4. Expression of putative limbal stem cell and corneal epi-
thelial cell markers in the sorted CD109 and CD200 positive and
negative cell populations. (A): Quantitative reverse transcriptase
polymerase chain reaction expression data for CD109+ limbal epi-
thelial cell population versus CD109− limbal epithelial cell popula-
tion represented by the red line (value 1). Values represent
mean  SEM, n = 3 (n, number of biological replicates), *, p < .05;
**, p < .01; ***, p < .001. (B): Quantitative reverse transcriptase
polymerase chain reaction expression data for CD200+ limbal epi-
thelial cell population versus CD200− limbal epithelial cell popula-
tion represented by the red line (value 1). Values represent
mean  SEM, n = 3, *, p < .05; **, p < .01; ***, p < .001.
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Taking into consideration this published literature and the
low frequency of CD200+ in our limbal epithelial cultures
(<5%), we hypothesized that CD200 may represent a potential
cell surface marker of LSCs. Using immunostaining in human
and mouse corneal tissue, we showed that CD200 is exclu-
sively located at the base of the limbal epithelium. In addition,
its expression is significantly and rapidly decreased upon sub-
sequent passaging and calcium induced differentiation of lim-
bal epithelial cells in keeping with a stem/transient amplifying
cell phenotype. CD200+ cells obtained from hair follicle have
been shown to possess a high CFE potential [35]; however our
findings do not support these results. We found no significant
difference between the CFE of CD200 positive and negative
populations. However, we showed that only CD200+ cells were
able to form holoclones which are derived from LSCs, while
CD200− cells produced meroclones which are known to
descend from transient amplifying cells. Moreover, we showed
that CD200+ cells are slow cycling and only start to enter the S
phase of the cells cycle after 8 hours long incubation with
BrdU, whereas CD200− cells enter the S phase 1 hour after
incubation with BrdU. Importantly, downregulation of CD200
by RNAi led to complete loss of holoclones, thus indicating an
important role for CD200 in the maintenance and /or self-
renewal of LSCs from which the holoclones are derived.
Both quiescent and active stem cell subpopulations coexist in
several tissues, in separate yet adjoining locations [15]. We
observed a higher number of Ki67− cells and lower expression of
Ki67 within the CD200+ population when compared to CD200−
cells, suggesting that CD200+ may represent the quiescent LSCs.
Indeed, a larger part of cells in G0 phase was made up with
CD200+ cell population which in itself contained 79% of the SP
cells, corroborating previously published findings by Umemoto
et al. that limbal epithelial SP are quiescent and do not
demonstrate proliferative capabilities in ex vivo culture conditions
[67]. We also observed a consistently higher expression of puta-
tive LSC markers including WNT7A, PAX6, ABCB5, CDH3, CK14,
and CK15 [12, 42, 43, 55, 68–71] in the CD200+ subpopulation.
In summary, we report herein the identification of a new
cell surface marker for LSCs (CD200) as well as a cell surface
marker for proliferating progenitor cells (CD109). We believe
that the identification of these two new cell surface markers
will significantly aid live enrichment of these two cell types
and their biological and clinical applications with potential
benefits for patients suffering with LSCD.
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